top of page

Advancing Drug Monitoring: California's Bold Step with AB 3073

AB 3073 California Wastewater Drug Testing
Body of contaminated water.

California is at the forefront of a groundbreaking initiative aimed at combating the escalating drug crisis with Assembly Bill 3073, the Wastewater Drug Testing Act. Spearheaded by Assemblymember Matt Haney, this pioneering legislation mandates large water treatment facilities to conduct comprehensive drug testing on wastewater samples. The move mirrors successful strategies deployed in Europe for over a decade, heralding a new era in proactive public health intervention.

Understanding AB 3073

AB 3073 authorizes the State Water Board, in collaboration with the State Department of Public Health, to compel local water agencies to collect and analyze wastewater samples for a range of illicit substances, including fentanyl, cocaine, methamphetamine, and xylazine. By harnessing the power of wastewater-based drug testing, California aims to pinpoint drug usage patterns at a granular, neighborhood level, enabling swift and targeted responses to emerging drug threats.

The Urgency of AB 3073 California Wastewater Drug Testing

The urgency underlying AB 3073 is underscored by sobering statistics. The surge in illicit drug use has exacerbated California's overdose epidemic, with fentanyl and Tranq-related deaths reaching alarming levels. In 2023 alone, San Francisco witnessed over 750 overdose-related fatalities, surpassing the toll of COVID-19 at its peak in 2021. Nationally, drug overdose deaths soared to an estimated 109,680 in 2022, averaging 300 fatalities daily, according to the CDC.

Wastewater-based drug testing is not a novel concept. With a track record spanning two decades in Europe, this technique has been instrumental in identifying drug hotspots and preemptively addressing emerging threats. Drawing parallels with the successful implementation of wastewater surveillance during the COVID-19 pandemic, AB 3073 leverages proven technology to combat the drug crisis head-on.

Key Provisions of AB 3073

Under AB 3073, local water agencies will be mandated to conduct wastewater testing at least twice weekly, ensuring a robust dataset for the State Department of Public Health to analyze drug trends. Moreover, the findings will be made accessible to the public via the health department's website, fostering community awareness and vigilance against evolving drug threats.

Assemblymember Haney emphasizes that despite the severity of the drug epidemic, the United States lags in adopting wastewater-based drug testing as a proactive measure. By harnessing this innovative approach, California aims to bridge this gap, empowering public health departments to identify and address drug trends before they escalate into fatal overdoses.

The Road Ahead

AB 3073 marks a pivotal step in California's fight against the opioid epidemic. As the bill advances to the Assembly Health Committee, its passage would signify a watershed moment, mandating statewide wastewater drug testing for the first time. By embracing innovation and evidence-based strategies, California is poised to redefine the landscape of drug monitoring and intervention.

Assembly Bill 3073 epitomizes California's unwavering commitment to safeguarding public health and combating the scourge of illicit drug use. Through proactive measures like wastewater-based drug testing, the state is forging a path toward targeted interventions, community empowerment, and ultimately, saving lives.


bottom of page